Advertisement
Screener

CASTLE BIOSCIENCES, INC. (CSTL) Graph

CSTL Revenue Flow

Filed revenue amounts for 2026-04-01 to 2026-06-30. Coverage is partial. Unconnected amounts are separate disclosures; they must not be added together.

  • 2026-06-30: Revenue $103.55M; Cost of revenue $23.70M; Research and development $14.54M; Selling, general and administrative $66.12M.
  • 2026-03-31: Revenue $83.68M; Cost of revenue $20.53M; Research and development $14.43M; Selling, general and administrative $64.90M.
  • 2025-12-31: Revenue $87.01M*; Cost of revenue $18.32M*; Research and development $13.52M*; Selling, general and administrative $56.73M*.
  • 2025-09-30: Revenue $83.04M; Cost of revenue $18.70M; Research and development $12.96M; Selling, general and administrative $55.91M.

Product or service

Separate filed amounts; connecting flows are not established. Components and totals may overlap.

CSTL revenue flowFiled amounts. Only explicit calculation relationships connect amounts; dimensional membership alone does not establish an additive flow.Dermatologic$48.70MNon Dermatologic$54.84MRevenue$103.55MCost of revenue$23.70MOperating income-$3.07MOther income, net-$153.00KResearch & development$14.54MSelling, general& administrative$66.12MIncome tax$370.00KNet income-$2.06M

Segment

Separate filed amounts; connecting flows are not established. Components and totals may overlap.

CSTL revenue flowFiled amounts. Only explicit calculation relationships connect amounts; dimensional membership alone does not establish an additive flow.Reportable Segment$103.55MRevenue$103.55MCost of revenue$23.70MOperating income-$3.07MOther income, net-$153.00KResearch & development$14.54MSelling, general& administrative$66.12MIncome tax$370.00KNet income-$2.06M

Finer product or service dollar figures and nonoverlapping groupings are shown only where supported by the retained filing evidence. Growth percentages are never converted to revenue dollars.

Historical revenue and expense breakdown

Revenue and expense 3 month

Period endRevenueCost of revenueResearch and developmentSelling, general and administrativeOperating expensesIncome taxNet income
2026-06-30$103.55M$23.70M$14.54M$66.12M(m)$370.00K-$2.06M
2026-03-31$83.68M$20.53M$14.43M$64.90M(m)$109.00K-$14.52M
2025-12-31$87.01M*$18.32M*$13.52M*$56.73M*(m)-$382.00K*-$2.33M*
2025-09-30$83.04M$18.70M$12.96M$55.91M(m)$115.00K-$501.00K
2025-06-30$86.19M$17.63M$12.79M$58.06M(m)-$4.67M$4.52M
2025-03-31$87.99M$16.38M$12.59M$58.62M(m)-$423.00K-$25.85M
2024-09-30$85.78M$15.61M$12.32M$50.50M(m)$6.01M$2.27M
2024-06-30$87.00M$14.52M$14.14M$51.09M(m)-$1.03M$8.92M
2024-03-31$72.97M$13.89M$13.81M$48.49M(m)$45.00K-$2.53M
2023-09-30$61.49M$11.32M$12.92M$44.62M(m)$32.00K-$6.91M
2023-06-30$50.14M$11.06M$13.31M$44.68M(m)$16.00K-$18.78M
2023-03-31$42.04M$10.18M$14.39M$46.76M(m)$14.00K-$29.20M
2022-09-30$37.01M$8.86M$10.91M$36.63M(m)$0.00-$20.25M
2022-06-30$34.84M$7.69M$11.93M$37.50M(m)-$1.96M-$1.65M
2022-03-31$26.85M$5.94M$10.76M$30.45M(m)$134.00K-$24.62M
2021-09-30$23.48M$4.50M$7.50M$22.59M(m)$0.00-$11.79M
2021-06-30$22.76M$3.70M$6.79M$20.82M(m)$5.00K-$8.79M
2021-03-31$22.81M$3.03M$5.91M$18.16M$24.07M$0.00-$4.28M
2020-12-31$17.30M(m)(m)(m)(m)(m)-$4.89M
2020-09-30$15.22M$2.48M$3.06M$11.70M(m)$0.00-$4.59M
2020-06-30$12.71M$2.15M$2.70M$10.39M(m)$0.00-$1.38M
2020-03-31$17.42M$2.39M$2.91M$11.08M$13.99M$0.00$570.00K
2019-12-31$17.64M(m)(m)(m)$13.01M*(m)$2.06M
2019-09-30$14.77M$1.71M$1.51M$7.12M$8.64M$0.00$5.85M
2019-06-30$10.74M$1.99M$1.32M$6.82M$8.14M$0.00-$1.27M
2019-03-31$8.72M$1.60M$1.39M$6.05M$7.44M$0.00-$1.36M
2018-12-31$11.44M(m)(m)(m)(m)(m)$3.87M
2018-09-30$3.71M$1.35M$1.29M$3.92M$5.21M$0.00-$3.45M
2018-06-30$3.98M$1.33M$1.16M$4.16M$5.32M$0.00-$3.15M
2018-03-31$3.66M(m)(m)(m)(m)(m)-$3.63M

Revenue and expense 6 month

Period endRevenueCost of revenueResearch and developmentSelling, general and administrativeOperating expensesIncome taxNet income
2026-06-30$187.22M$44.23M$28.97M$131.02M(m)$479.00K-$16.58M
2025-06-30$174.18M$34.01M$25.38M$116.69M(m)-$5.09M-$21.32M
2024-06-30$159.98M$28.41M$27.95M$99.58M(m)-$989.00K$6.39M
2023-06-30$92.17M$21.24M$27.70M$91.44M(m)$30.00K-$47.98M
2022-06-30$61.69M$13.63M$22.69M$67.95M(m)-$1.82M-$26.27M
2021-06-30$45.57M$6.72M$12.70M$38.98M(m)$5.00K-$13.07M
2020-06-30$30.13M$4.54M$5.62M$21.47M(m)$0.00-$806.00K
2019-06-30$19.46M$3.59M$2.71M$12.87M$15.58M$0.00-$2.63M
2018-06-30$7.64M$2.58M$2.42M$8.39M$10.81M$0.00-$6.79M

Revenue and expense 9 month

Period endRevenueCost of revenueResearch and developmentSelling, general and administrativeOperating expensesIncome taxNet income
2025-09-30$257.22M$52.71M$38.34M$172.59M(m)-$4.97M-$21.83M
2024-09-30$245.76M$44.02M$40.27M$150.08M(m)$5.02M$8.65M
2023-09-30$153.67M$32.56M$40.62M$136.06M(m)$62.00K-$54.89M
2022-09-30$98.70M$22.49M$33.59M$104.58M(m)-$1.82M-$46.52M
2021-09-30$69.05M$11.22M$20.20M$61.58M(m)$5.00K-$24.86M
2020-09-30$45.35M$7.01M$8.68M$33.17M(m)$0.00-$5.39M
2019-09-30$34.23M$5.30M$4.23M$19.99M$24.22M$0.00$3.22M
2018-09-30$11.35M$3.93M$3.72M$12.31M$16.02M$0.00-$10.24M

Revenue and expense 12 month

Period endRevenueCost of revenueResearch and developmentSelling, general and administrativeOperating expensesIncome taxNet income
2025-12-31$344.23M$71.03M$51.85M$229.32M(m)-$5.36M-$24.16M
2024-12-31$332.07M$60.20M$52.04M$200.05M(m)$3.32M$18.25M
2023-12-31$219.79M$44.98M$53.62M$180.15M(m)$101.00K-$57.47M
2022-12-31$137.04M$32.01M$44.90M$143.00M(m)-$1.77M-$67.14M
2021-12-31$94.08M$15.82M$29.65M$86.74M(m)-$8.72M-$31.29M
2020-12-31$62.65M$9.69M$13.26M$48.13M(m)$84.00K-$10.28M
2019-12-31$51.87M$7.31M$7.38M$29.84M$37.23M$72.00K$5.28M
2018-12-31$22.79M$5.30M$4.85M$16.47M$21.32M$9.00K-$6.37M

Similar stocks

Stock NameCountryMarket CapPE Ratio
Lumexa Imaging Holdings, Inc. (LMRI)United States$0.951B
Fulgent Genetics, Inc. (FLGT)United States$0.593B-6.70
Personalis, Inc. (PSNL)United States$1.769B-13.30
BIODESIX INC (BDSX)United States$0.312B
Fortrea Holdings Inc. (FTRE)United States$1.903B-19.43
EXAGEN INC. (XGN)United States$0.212B-5.95
Freenome, Inc. (FRNM)United States$0.143B
SERA PROGNOSTICS, INC. (SERA)United States$0.062B-5.75
AMERICAN SHARED HOSPITAL SERVICES (AMS)United States$0.010B-5.64
Advanced Biomed Inc. (ADVB)$0.009B